CD8A and lung cancer: On the other hand, effector CD8+ T cells double-transfected to express HLA-A*2402-restricted and WT1235–243-specific-TCR successfully killed candidate human lung cancer cell lines in an HLA-A*2402-restricted manner (Fig. 1C and 1D).